The market for advanced biopsy devices in the US is experiencing robust growth, fueled by escalating cancer incidence, a push for minimally invasive diagnostics, and groundbreaking technological advancements. The US market for biopsy devices, valued at a substantial USD 5.06 billion in 2024, is poised for significant expansion, projected to climb to USD 7.36 billion by 2032. This growth...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek